56211-40-6 | 1-{4-[(3-methylphenyl)amino]pyridine-3-sulfonyl}-3-(propan-2-yl)urea

Packsize	Purity	Availability	Price	Discounted Price
1g	98%(HPLC)	in stock	$25.00	$18.00
5g	98%	in stock	$50.00	$35.00
25g	98%	in stock	$163.00	$114.00
100g	98%	in stock	$511.00	$358.00

Description

• Catalog Number: AB79738
• Chemical Name: 1-{4-[(3-methylphenyl)amino]pyridine-3-sulfonyl}-3-(propan-2-yl)urea
• CAS Number: 56211-40-6
• Molecular Formula: C16H20N4O3S
• Molecular Weight: 348.4200
• MDL Number: MFCD00866166
• SMILES: CC(NC(=O)NS(=O)(=O)c1cnccc1Nc1cccc(c1)C)C

Computed Properties

• Complexity: 518
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 24
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 5
• XLogP3: 2.7

Literature

• Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

  Chemical research in toxicology 20150518

• In right or biventricular chronic heart failure addition of thiazides to loop diuretics to achieve a sequential blockade of the nephron is associated with increased risk of dilutional hyponatremia: results of a case-control study.

  Minerva cardioangiologica 20121001

• [Use of neurostimulation in a patient with an implantable cardioverter defibrillator (ICD)].

  Deutsche medizinische Wochenschrift (1946) 20121001

• Should torsemide be the loop diuretic of choice in systolic heart failure?

  Future cardiology 20120901

• Chemometrically assisted development and validation of LC-UV and LC-MS methods for simultaneous determination of torasemide and its impurities.

  Journal of chromatographic science 20120401

• Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease.

  Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology 20120301

• The genetics of loop diuretic effects.

  The pharmacogenomics journal 20120201

• Potential drug-drug interactions and adverse drug reactions in patients with liver cirrhosis.

  European journal of clinical pharmacology 20120201

• Adverse drug reactions in a complementary medicine hospital: a prospective, intensified surveillance study.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Higher Blood Glucose within the Normal Range Is Associated with More Severe Strokes.

  Stroke research and treatment 20120101

• In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.

  Minerva cardioangiologica 20111201

• Use of the loop diuretic torsemide in three dogs with advanced heart failure.

  Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Spinal epidural hematoma related to an epidural catheter in a cardiac surgery patient -A case report-.

  Korean journal of anesthesiology 20111201

• Some sulfonamide drugs inhibit ATPase activity of heat shock protein 90: investigation by docking simulation and experimental validation.

  Journal of enzyme inhibition and medicinal chemistry 20111001

• Study on the interaction between torasemide and 12-tungstophosphoric acid by resonance Rayleigh scattering and resonance nonlinear scattering spectra and its analytical applications.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110901

• Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.

  Clinical therapeutics 20110901

• Drug-induced photodermatitis in elderly nursing home residents.

  Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20110801

• Temporary bilateral sensorineural hearing loss following cardiopulmonary bypass -A case report-.

  Korean journal of anesthesiology 20110801

• [Postpartum cardiomyopathy].

  Deutsche medizinische Wochenschrift (1946) 20110601

• [Treatment of nephritic edema by torasemide in children].

  Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20110601

• Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices.

  European heart journal 20110501

• [Etiologies of nephrotic syndrome].

  Praxis 20110427

• A case of a false-positive anti-myeloperoxidase antibody ELISA in a patient with hypothyroidism.

  Chonnam medical journal 20110401

• Nontarget analysis of polar contaminants in freshwater sediments influenced by pharmaceutical industry using ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry.

  Environmental pollution (Barking, Essex : 1987) 20110201

• Reversed-phase ultra-performance liquid chromatographic method development and validation for determination of impurities related to torsemide tablets.

  Journal of AOAC International 20110101

• Sex differences in drug disposition.

  Journal of biomedicine & biotechnology 20110101

• Role of the kidneys in resistant hypertension.

  International journal of hypertension 20110101

• The causes, consequences, and treatment of left or right heart failure.

  Vascular health and risk management 20110101

• [Torasemide is the effective loop diuretic for long-term therapy of arterial hypertension].

  Kardiologiia 20110101

• [Alternative therapy with ivabradine in patients with functional class III chronic heart failure].

  Kardiologiia 20110101

• Anti-albuminuric effects of the angiotensin AT1 receptor blocker telmisartan in hypertensive patients.

  Clinical and experimental hypertension (New York, N.Y. : 1993) 20110101

• Management of renal failure and ascites in patients with cirrhosis.

  International journal of hepatology 20110101

• Diuretics induced uremia and nonrecovery of renal function in a patient with acute renal failure caused by sepsis.

  Indian journal of pharmacology 20110101

• Targeting cardiac fibrosis: a new frontier in antiarrhythmic therapy?

  American journal of cardiovascular disease 20110101

• Etoricoxib-induced life-threatening hyperkalemia and acute kidney dysfunction against the background of telmisartan and a low sodium diet.

  International journal of emergency medicine 20101201

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Congestive heart failure in Indians: how do we improve diagnosis & management?

  The Indian journal of medical research 20101101

• Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction.

  European journal of heart failure 20100901

• [A new case of nevus oligemicus].

  Dermatology online journal 20100815

• The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction.

  European journal of heart failure 20100701

• Mannitol is an independent risk factor of acute kidney injury after cerebral trauma: a case-control study.

  Renal failure 20100701

• Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?

  European journal of heart failure 20100701

• [Update: prolonged-release torasemide].

  Drugs of today (Barcelona, Spain : 1998) 20100701

• Hypertensive brainstem encephalopathy involving deep supratentorial regions: does only blood pressure matter?

  Neurology international 20100621

• Multi-residue analysis of pharmaceutical compounds in wastewaters by dual solid-phase microextraction coupled to liquid chromatography electrospray ionization ion trap mass spectrometry.

  Journal of chromatography. A 20100514

• Recurrent syncope and hypocalcaemic cardiomyopathy as manifestations of Fahr's syndrome.

  Archives of medical science : AMS 20100301

• Gender is an important determinant of the disposition of the loop diuretic torasemide.

  Journal of clinical pharmacology 20100201

• Agents with antialdosterone properties should be the preferred diuretics for reducing hypertension related atrial fibrillation.

  European journal of internal medicine 20100201

• [Determination of brain natriuretic peptide levels and its N-terminal fragment for the evaluation of renal replacement therapies efficiency in patients with decompensated chronic heart failure].

  Terapevticheskii arkhiv 20100101

• Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases.

  PloS one 20100101

• A comprehensive review of the loop diuretics: should furosemide be first line?

  The Annals of pharmacotherapy 20091101

• [Frequent drug interactions in old age].

  Praxis 20091021

• The role of transporters in the pharmacokinetics of orally administered drugs.

  Pharmaceutical research 20090901

• TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.

  Expert review of cardiovascular therapy 20090801

• Torasemide prolonged release.

  Drugs 20090709

• Characterization of the binding of drugs to human intestinal fatty acid binding protein (IFABP): potential role of IFABP as an alternative to albumin for in vitro-in vivo extrapolation of drug kinetic parameters.

  Drug metabolism and disposition: the biological fate of chemicals 20090701

• [Effects of various diuretics on cardiac function in rats with heart failure].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20090701

• [Intoxication with lithium].

  Praxis 20090624

• Loop diuretics in patients with heart failure: time to change to torsemide?

  Journal of cardiovascular pharmacology 20090601

• Beneficial effects of torasemide on systolic wall stress and sympathetic nervous activity in asymptomatic or mildly symptomatic patients with heart failure: comparison with azosemide.

  Journal of cardiovascular pharmacology 20090601

• Torasemide significantly reduces thiazide-induced potassium and magnesium loss despite supra-additive natriuresis.

  European journal of clinical pharmacology 20090501

• A bioavailability/bioequivalence and pharmacokinetic study of two oral doses of torasemide (5 and 10 mg): prolonged-release versus the conventional formulation.

  Clinical and experimental pharmacology & physiology 20090501

• 4-(3-Methyl-anilino)-N-[N-(1-methyl-ethyl)carbamo-yl]pyridinium-3-sulfon-amidate (torasemide) methanol 0.25-solvate 0.25-hydrate.

  Acta crystallographica. Section E, Structure reports online 20090501

• 4-(3-Methyl-anilino)-N-[N-(1-methyl-ethyl)carbamo-yl]pyridinium-3-sulfon-amidate (torasemide T-N): a low temperature redetermination.

  Acta crystallographica. Section E, Structure reports online 20090501

• Prediction of the effects of genetic polymorphism on the pharmacokinetics of CYP2C9 substrates from in vitro data.

  Pharmaceutical research 20090401

• Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure.

  Hypertension (Dallas, Tex. : 1979) 20090201

• Linking binge alcohol-induced neurodamage to brain edema and potential aquaporin-4 upregulation: evidence in rat organotypic brain slice cultures and in vivo.

  Journal of neurotrauma 20090201

• Comparison of repeated-dose pharmacokinetics of prolonged-release and immediate-release torasemide formulations in healthy young volunteers.

  Fundamental & clinical pharmacology 20090201

• The management of acute heart failure and diuretic therapy.

  American journal of therapeutics 20090101

• Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.

  American journal of therapeutics 20090101

• Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.

  Current medicinal chemistry 20090101

• Management of ascites due to gastrointestinal malignancy.

  Annals of Saudi medicine 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Successful treatment of severe sinusoidal obstruction syndrome despite multiple organ failure with defibrotide after allogeneic stem cell transplantation: a case report.

  Journal of medical case reports 20090101

• Drugs impact on CYP-450 enzyme family: A pharmacogenetical study of response variation.

  Indian journal of human genetics 20090101

• Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4.

  British journal of pharmacology 20081201

• Probable interaction between warfarin and torsemide.

  The Annals of pharmacotherapy 20081201

• Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide.

  Kidney international. Supplement 20081201

• [Hypertension, hypertensive heart disease and heart failure. Role of loop diuretics].

  Medicina clinica 20081115

• Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension.

  Chronobiology international 20081101

• Efficacy and safety of torasemide in children with heart failure.

  Archives of disease in childhood 20080901

• The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamics.

  Clinical pharmacology and therapeutics 20080601

• The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients.

  Journal of cardiac failure 20080601

• Torasemide for the treatment of heart failure.

  Cardiovascular & hematological disorders drug targets 20080601

• Torsemide-induced pseudoporphyria.

  Archives of dermatology 20080601

• Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation.

  The Annals of pharmacotherapy 20080301

• The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.

  Clinical therapeutics 20080301

• Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy.

  European journal of pharmacology 20080226

• Comparative effects of torasemide and furosemide in rats with heart failure.

  Biochemical pharmacology 20080201

• Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.

  European journal of clinical pharmacology 20080201

• Pharmacologic approaches for volume excess in acute kidney injury (AKI).

  The International journal of artificial organs 20080201

• Secondary pulmonary hypertension: haemodynamic effects of torasemide versus furosemide.

  Clinical drug investigation 20080101

• Determinants of steady-state torasemide pharmacokinetics: impact of pharmacogenetic factors, gender and angiotensin II receptor blockers.

  Clinical pharmacokinetics 20080101

• Clinical effects of torasemide prolonged release in mild-to-moderate hypertension: a randomized noninferiority trial versus torasemide immediate release.

  Cardiovascular therapeutics 20080101

• NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy.

  PloS one 20080101

• [Loop diuretics in the treatment of edema: torasemide potentials].

  Terapevticheskii arkhiv 20080101

• A simplified HPLC method for quantification of torsemide from human plasma and its application to a bioequivalence study.

  Indian journal of pharmaceutical sciences 20080101

• Torasemide transport by organic anion transporters contributes to hyperuricemia.

  Journal of the American Society of Nephrology : JASN 20071201

• [Efficacy of monotherapy with 15 antihypertensive agents in treating essential hypertension assessed by 24-hour ambulatory blood pressure monitoring].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20071201

• Effects of oral administration of furosemide and torsemide in healthy dogs.

  American journal of veterinary research 20071001

• Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the effects of loop diuretic drugs.

  Clinical pharmacology and therapeutics 20070901

• Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.

  Journal of the American College of Cardiology 20070828

• Effect of torsemide on serum and urine electrolyte levels in dogs with congestive heart failure.

  The Veterinary record 20070616

• Genetic variation at the CYP2C locus and its association with torsemide biotransformation.

  The pharmacogenomics journal 20070601

• Gender difference in the pharmacokinetic interaction between oral warfarin and oxolamine in rats: inhibition of CYP2B1 by oxolamine in male rats.

  Biopharmaceutics & drug disposition 20070401

• Hospital policies for treatment of acute decompensated heart failure.

  The Annals of pharmacotherapy 20070401

• Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis.

  Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 20070301

• Vasodilatory action of loop diuretics: a plethysmography study of endothelial function in forearm arteries and dorsal hand veins in hypertensive patients and controls.

  Journal of cardiovascular pharmacology 20070201

• [Chronotherapy with torasemide in hypertensive patients: increased efficacy and therapeutic coverage with bedtime administration].

  Medicina clinica 20061118

• Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure.

  The American journal of cardiology 20061115

• Classification of torasemide based on the Biopharmaceutics Classification System and evaluation of the FDA biowaiver provision for generic products of CLASS I drugs.

  The Journal of pharmacy and pharmacology 20061101

• Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.

  Heart (British Cardiac Society) 20061001

• Efficacy and safety of a furosemide continuous infusion following cardiac surgery.

  The Annals of pharmacotherapy 20061001

• Evaluation of original dual thromboxane A2 modulators as antiangiogenic agents.

  The Journal of pharmacology and experimental therapeutics 20060901

• Torsemide renal clearance and genetic variation in luminal and basolateral organic anion transporters.

  British journal of clinical pharmacology 20060901

• Relation of loop diuretic dose to mortality in advanced heart failure.

  The American journal of cardiology 20060615

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Improved solid-phase extraction and HPLC measurement of torasemide and its important metabolites.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20060202

• Probable loop diuretic-induced pancreatitis in a sulfonamide-allergic patient.

  The Annals of pharmacotherapy 20060101

• [Diuretic therapy in heart failure].

  Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20060101

• [Clinical efficacy and safety of administration of loop diuretic torasemide].

  Kardiologiia 20060101

• Cardiomyopathy, familial dilated.

  Orphanet journal of rare diseases 20060101

• Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report.

  BMC cancer 20060101

• [A case of severe hyponatremia in a patient suffering from epilepsy and using oxcarbazepine].

  Medicina (Kaunas, Lithuania) 20060101

• [Torasemide--new generation loop diuretic: clinical pharmacology and therapeutic application].

  Kardiologiia 20060101

• Functional characterization of human monocarboxylate transporter 6 (SLC16A5).

  Drug metabolism and disposition: the biological fate of chemicals 20051201

• Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin.

  Biopharmaceutics & drug disposition 20051101

• Comparison of the urine acidification tests of torsemide vs furosemide in healthy volunteers.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20051101

• Screening procedure for detection of diuretics and uricosurics and/or their metabolites in human urine using gas chromatography-mass spectrometry after extractive methylation.

  Therapeutic drug monitoring 20050801

• Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous torasemide in rats.

  International journal of pharmaceutics 20050714

• Dose-independent pharmacokinetics of torasemide after intravenous and oral administration to rats.

  Biopharmaceutics & drug disposition 20050701

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• Electrochemical characterisation of the human cytochrome P450 CYP2C9.

  Biochemical pharmacology 20050515

• Embolic infarction associated with cardiac amyloidosis.

  Journal of clinical neurology (Seoul, Korea) 20050401

• [Aldosterone antagonist therapy for chronic heart failure].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20050210

• Pharmacological profile and therapeutic potential of BM-573, a combined thromboxane receptor antagonist and synthase inhibitor.

  Cardiovascular drug reviews 20050101

• Torsemide versus furosemide after continuous renal replacement therapy due to acute renal failure in cardiac surgery patients.

  Renal failure 20050101

• [The place of diuretics in the treatment of chronic heart failure. Part I].

  Kardiologiia 20050101

• [Valsartan in patients with arterial hypertension and type 2 diabetes mellitus. The lapaval study].

  Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20050101

• High-Dose Torasemide is Equivalent to High-Dose Furosemide with Hypertonic Saline in the Treatment of Refractory Congestive Heart Failure.

  Clinical drug investigation 20050101

• Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure.

  Journal of the American College of Cardiology 20041207

• Mechanism-based inactivation of human cytochrome P4502C8 by drugs in vitro.

  The Journal of pharmacology and experimental therapeutics 20041201

• CYP2C9 polymorphisms and the interindividual variability in pharmacokinetics and pharmacodynamics of the loop diuretic drug torsemide.

  Clinical pharmacology and therapeutics 20041201

• Pharmacological evaluation of both enantiomers of (R,S)-BM-591 as thromboxane A2 receptor antagonists and thromboxane synthase inhibitors.

  Prostaglandins & other lipid mediators 20041001

• A woman with infectious endocarditis caused by Abiotrophia defectiva.

  Internal medicine (Tokyo, Japan) 20041001

• Effects of cysteine on the pharmacokinetics of intravenous torasemide in rats with protein-calorie malnutrition.

  Journal of pharmaceutical sciences 20040901

• Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of torasemide in rabbits.

  Biopharmaceutics & drug disposition 20040701

• Differential contribution of active site residues in substrate recognition sites 1 and 5 to cytochrome P450 2C8 substrate selectivity and regioselectivity.

  Biochemistry 20040622

• Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure.

  Journal of the American College of Cardiology 20040602

• Pharmacological characterization of N-tert-butyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time.

  The Journal of pharmacology and experimental therapeutics 20040501

• Food: an unrecognized source of loop diuretic resistance.

  Pharmacotherapy 20040501

• [Idiopathic hypereosinophilia with cardiac involvement].

  Deutsche medizinische Wochenschrift (1946) 20040312

• Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs).

  Advanced drug delivery reviews 20040223

• Optimizing bacterial expression of catalytically active human cytochromes P450: comparison of CYP2C8 and CYP2C9.

  Xenobiotica; the fate of foreign compounds in biological systems 20040101

• Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV--efficacy and quality of life.

  European journal of heart failure 20031201

• Role of excess volume in the pathophysiology of hypertension in chronic kidney disease.

  Kidney international 20031101

• Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous torasemide.

  The Journal of pharmacy and pharmacology 20031101

• Identification and prediction of promiscuous aggregating inhibitors among known drugs.

  Journal of medicinal chemistry 20031009

• [Heart failure therapy. Cheap can become expensive].

  MMW Fortschritte der Medizin 20031009

• The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats.

  The Journal of veterinary medical science 20031001

• [Diuretics in heart failure. Fewer electrolyte disorders -- better prognosis].

  MMW Fortschritte der Medizin 20030807

• A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.

  Kidney international 20030801

• [Favorable prognostic effect of heart failure therapy. Diuretic makes heart muscle more elastic].

  MMW Fortschritte der Medizin 20030605

• Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure.

  Circulation journal : official journal of the Japanese Circulation Society 20030501

• [Hear failure. Indications for diuretic therapy in general practice].

  MMW Fortschritte der Medizin 20030501

• Multivariate optimisation of a cyclodextrin-assisted-capillary zone electrophoretic method for the separation of torasemide and its metabolites.

  Journal of chromatography. A 20030321

• [Reducing hospital stay and costs in heart failure. The proper diuretic makes the difference].

  MMW Fortschritte der Medizin 20030123

• Ethacrynic acid and the sulfa-sensitive patient.

  Archives of internal medicine 20030113

• Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats.

  Biopharmaceutics & drug disposition 20030101

• Pharmacological evaluation of the novel thromboxane modulator BM-567 (I/II). Effects of BM-567 on platelet function.

  Prostaglandins, leukotrienes, and essential fatty acids 20030101

• [Torasemide (Trifas) in clinical practice--own experience].

  Przeglad lekarski 20030101

• Calciphylaxis in chronic, non-dialysis-dependent renal disease.

  BMC nephrology 20030101

• Pharmacotherapy in congestive heart failure: drug absorption in the management of congestive heart failure: loop diuretics.

  Congestive heart failure (Greenwich, Conn.) 20030101

• Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous torasemide in rats.

  Research communications in molecular pathology and pharmacology 20030101

• [Which loop diuretic for heart failure? For prognosis the choices are not all the same].

  MMW Fortschritte der Medizin 20021003

• [Long-term diuretic treatment in heart failure: are there differences between furosemide and torasemide?].

  Praxis 20020911

• [A better diuretic for patients with heart failure. Better control of potassium loss].

  MMW Fortschritte der Medizin 20020808

• Torasemide in chronic heart failure: results of the TORIC study.

  European journal of heart failure 20020801

• [Which diuretic in heart failure? For the prognosis, they are not all equal].

  MMW Fortschritte der Medizin 20020328

• Diuretics in the therapy of hypertension.

  Journal of human hypertension 20020301

• Crystal forms of torasemide: new insights.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20020101

• Separation of the high-ceiling diuretic Torasemide and its metabolites by capillary zone electrophoresis with diode-array detection.

  Electrophoresis 20020101

• [Aggression to the immature kidney].

  La Pediatria medica e chirurgica : Medical and surgical pediatrics 20020101

• [Diuretics in heart failure. Can they also prolong life?].

  MMW Fortschritte der Medizin 20011206

• Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.

  The American journal of medicine 20011101

• Optimal diuretic therapy for heart failure.

  The American journal of medicine 20011101

• Simultaneous determination of torasemide and its major metabolite M5 in human urine by high-performance liquid chromatography-electrochemical detection.

  Journal of chromatographic science 20011101

• [Treatment of ascites in cirrhotic patients].

  Anales del sistema sanitario de Navarra 20010901

• [Torasemide (LUPRAC): a review of its pharmacological and clinical profile].

  Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20010801

• Activity of a novel dual thromboxane A(2)receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles.

  Prostaglandins, leukotrienes, and essential fatty acids 20010801

• Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitor.

  The Journal of pharmacy and pharmacology 20010501

• Intraplatelet calcium levels in patients with acute renal failure before and after the administration of loop diuretics.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010301

• Long-term efficacy of torsemide compared with frusemide in cirrhotic patients with ascites.

  Scandinavian journal of gastroenterology 20010301

• Effects of loop diuretics on angiotensin II-stimulated vascular smooth muscle cell growth.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010101

• The loop diuretic torasemide interferes with endothelin-1 actions in the aorta of hypertensive rats.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010101

• Torasemide: a pharmacoeconomic review of its use in chronic heart failure.

  PharmacoEconomics 20010101

• Pharmacology of the thromboxane receptor antagonist and thromboxane synthase inhibitor BM-531.

  Cardiovascular drug reviews 20010101

• Torasemide--a unique loop diuretic.

  Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20010101

• Allelic and functional variability of cytochrome P4502C9.

  Pharmacogenetics 19970201

• Delayed progression of cytotoxic oedema in focal cerebral ischemia after treatment with a torasemide derivative: a diffusion-weighted magnetic resonance imaging study.

  Neuroscience letters 19960802

• Torasemide. An update of its pharmacological properties and therapeutic efficacy.

  Drugs 19950101

• FDA approved new drug bulletin: torsemide (Demadex), trimetrexate glucuronate (neuTrexin).

  RN 19940501

• Diuretic and vasodilating actions of torasemide.

  Cardiology 19940101

• Comparative analysis of torasemide and furosemide in liver cirrhosis.

  Cardiology 19940101

• Torasemide. A review of its pharmacological properties and therapeutic potential.

  Drugs 19910101